Literature DB >> 20648061

GSK3 signalling in neural development.

Eun-Mi Hur1, Feng-Quan Zhou.   

Abstract

Recent evidence suggests that glycogen synthase kinase 3 (GSK3) proteins and their upstream and downstream regulators have key roles in many fundamental processes during neurodevelopment. Disruption of GSK3 signalling adversely affects brain development and is associated with several neurodevelopmental disorders. Here, we discuss the mechanisms by which GSK3 activity is regulated in the nervous system and provide an overview of the recent advances in the understanding of how GSK3 signalling controls neurogenesis, neuronal polarization and axon growth during brain development. These recent advances suggest that GSK3 is a crucial node that mediates various cellular processes that are controlled by multiple signalling molecules--for example, disrupted in schizophrenia 1 (DISC1), partitioning defective homologue 3 (PAR3), PAR6 and Wnt proteins--that regulate neurodevelopment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20648061      PMCID: PMC3533361          DOI: 10.1038/nrn2870

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  131 in total

1.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

Authors:  S Frame; P Cohen; R M Biondi
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

2.  Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

Authors:  R Dajani; E Fraser; S M Roe; N Young; V Good; T C Dale; L H Pearl
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

3.  Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway.

Authors:  Takeshi Yoshimura; Nariko Arimura; Yoji Kawano; Saeko Kawabata; Shujie Wang; Kozo Kaibuchi
Journal:  Biochem Biophys Res Commun       Date:  2005-12-06       Impact factor: 3.575

4.  CRMP-2 induces axons in cultured hippocampal neurons.

Authors:  N Inagaki; K Chihara; N Arimura; C Ménager; Y Kawano; N Matsuo; T Nishimura; M Amano; K Kaibuchi
Journal:  Nat Neurosci       Date:  2001-08       Impact factor: 24.884

5.  GSK-3beta directly phosphorylates and activates MARK2/PAR-1.

Authors:  Shinichi Kosuga; Etsu Tashiro; Toshifumi Kajioka; Mayumi Ueki; Yoshifumi Shimizu; Masaya Imoto
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

Review 6.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

7.  CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium.

Authors:  C A Grimes; R S Jope
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

Review 8.  Judging a protein by more than its name: GSK-3.

Authors:  J R Woodgett
Journal:  Sci STKE       Date:  2001-09-18

9.  A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons.

Authors:  Antonella Riccio; Rebecca S Alvania; Bonnie E Lonze; Narendrakumar Ramanan; Taeho Kim; Yunfei Huang; Ted M Dawson; Solomon H Snyder; David D Ginty
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

Review 10.  Where is APC going?

Authors:  Y Mimori-Kiyosue; S Tsukita
Journal:  J Cell Biol       Date:  2001-09-17       Impact factor: 10.539

View more
  346 in total

1.  GSK3 controls axon growth via CLASP-mediated regulation of growth cone microtubules.

Authors:  Eun-Mi Hur; Byoung Dae Lee; Seong-Jin Kim; Wen-Lin Xu; Feng-Quan Zhou
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

Review 2.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

3.  Cdc42 and Gsk3 modulate the dynamics of radial glial growth, inter-radial glial interactions and polarity in the developing cerebral cortex.

Authors:  Yukako Yokota; Tae-Yeon Eom; Amelia Stanco; Woo-Yang Kim; Sarada Rao; William D Snider; E S Anton
Journal:  Development       Date:  2010-12       Impact factor: 6.868

4.  Novel GαS-protein signaling associated with membrane-tethered amyloid precursor protein intracellular domain.

Authors:  Carole Deyts; Kulandaivelu S Vetrivel; Shibandri Das; Yumiko M Shepherd; Denis J Dupré; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

5.  Prenatal Alcohol Exposure Leads to Enhanced Serine 9 Phosphorylation of Glycogen Synthase Kinase-3β (GSK-3β) in the Hippocampal Dentate Gyrus of Adult Mouse.

Authors:  Lee Anna Cunningham; Jessie Newville; Lu Li; Phillip Tapia; Andrea M Allan; C Fernando Valenzuela
Journal:  Alcohol Clin Exp Res       Date:  2017-10-03       Impact factor: 3.455

6.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

7.  Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3.

Authors:  Martin Golkowski; Gayani K Perera; Venkata Narayana Vidadala; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Shao-En Ong
Journal:  Mol Omics       Date:  2018-02-12

8.  Inhibitory phosphorylation of GSK-3β by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP).

Authors:  Xiaoming Zhou; Hong Wang; Maurice B Burg; Joan D Ferraris
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-16

9.  Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.

Authors:  Jose A Morales-Garcia; Valle Palomo; Miriam Redondo; Sandra Alonso-Gil; Carmen Gil; Ana Martinez; Ana Perez-Castillo
Journal:  ACS Chem Neurosci       Date:  2014-01-17       Impact factor: 4.418

10.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.